-
Innovation Ranking
NewInnovation Ranking – GEA Group AG
GEA Group AG (GEA) is an engineering group that develops and manufactures process technologies and components. It specializes in machinery, plants, and also process technology and components. GEA provides separators, homogenizers, valves, pumps, and refrigeration equipment. The company offers process technology, feeding systems, dairy equipment, and slurry engineering. It serves customers in beverage, leisure and sport, dairy farming, food, home and personal care, dairy processing, transportation, marine, pharmaceutical, chemical, and utility sectors in Asia Pacific, Latin America, North America, Europe,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GEA-001 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GEA-001 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GEA-001 in Rheumatoid Arthritis Drug Details: GEA-001 is under development for the...
-
Company Insights
Innovation and Patenting activity of GEA Group AG Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of GEA Group AG Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Santo Cristo de Magallon
Santo Cristo de Magallon is an Onshore Wind project located in Aragon, Spain. The project is owned by Macquarie European Infrastructure Fund and was developed by GEA Magallon II S.L.. The project came online in 2006. Empower your strategies with our Santo Cristo de Magallon report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Sector Analysis
Green Bites – Key Disruptive Forces in Sustainable Nutrition
Disruptive Forces in Sustainable Nutrition Report Overview Advanced developments such as edible insects, food 3D printing, and plant-based proteins are redefining food efficiency and environmental impact in the sustainable nutrition domain. Innovation Curve: Consumer Buy the Full Report to Know More about the Disruptive Forces in Sustainable Nutrition Download a Free Report Sample The ‘Green Bites – Key Disruptive Forces in Sustainable Nutrition’ FutureTech series report categorizes the key innovation areas in sustainable nutrition as emerging, accelerating, and maturing. The...
-
Product Insights
GEA Grp – Elsdorf Pharmaceutical Technology Center Development – North Rhine-Westphalia
Equip yourself with the essential tools needed to make informed and profitable decisions with our GEA Grp - Elsdorf Pharmaceutical Technology Center Development - North Rhine-Westphalia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
Pargesa Holding SA – Company Profile
Pargesa SA (Pargesa) is an investment holding company. Its main shareholdings include GBL, Imerys SA, Canyon, Voodoo, Adidas, Pernod Ricard SA, SGS SA, Umicore NV/SA, Mqwi, GEA, Ontex, Webhelp, Sienna, and Parques Reunidos. The company invests in various industries including minerals processing, oil and gas, energy, health, alcoholic beverages, water and waste management, and building materials. The company offers energy solutions, oil and gas products, chemical solutions, renewable energy, filtration and performance additives products, ceramic materials, and fused minerals and...
Add to Basket -
Company Profile
GEA Group AG – Company Profile
GEA Group AG (GEA) is an engineering group that develops and manufactures process technologies and components. It specializes in machinery, plants, and also process technology and components. GEA provides separators, homogenizers, valves, pumps, and refrigeration equipment. The company offers process technology, feeding systems, dairy equipment, and slurry engineering. It serves customers in beverage, leisure and sport, dairy farming, food, home and personal care, dairy processing, transportation, marine, pharmaceutical, chemical, and utility sectors in Asia Pacific, Latin America, North America, Europe,...
Add to Basket -
Product Insights
GEA – Opera House – Ar Riyad
Equip yourself with the essential tools needed to make informed and profitable decisions with our GEA - Opera House - Ar Riyad report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the GEA...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GEA-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GEA-001 Drug Details GEA-001 is under development for the treatment of coronavirus disease 2019...